![]() |
Volumn 352, Issue 15, 2005, Pages 1608-1610
|
Prophylaxis against rabies [4] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMALARIAL AGENT;
CHLOROQUINE;
RABIES IMMUNOGLOBULIN;
RABIES VACCINE;
IMMUNOGLOBULIN;
VIRUS ANTIBODY;
ANTIBODY RESPONSE;
ANTIBODY TITER;
DEVELOPED COUNTRY;
DOG BITE;
DRUG POTENCY;
ENDEMIC DISEASE;
EXPOSURE;
HIGH RISK POPULATION;
HUMAN;
IMMUNE RESPONSE;
INCUBATION TIME;
INFECTION RISK;
LETTER;
NONHUMAN;
PRIORITY JOURNAL;
RABIES;
WORLD HEALTH ORGANIZATION;
ANIMAL;
BITES AND STINGS;
DOG;
IMMUNOLOGY;
INTRADERMAL DRUG ADMINISTRATION;
NOTE;
RABIES VIRUS;
DRUG INTERACTION;
ECONOMICS;
INTRAMUSCULAR DRUG ADMINISTRATION;
MALARIA;
DEVELOPING COUNTRY;
DISEASE TRANSMISSION;
ISOLATION AND PURIFICATION;
SALIVA;
TIME;
VIROLOGY;
ANIMALS;
ANTIBODIES, VIRAL;
BITES AND STINGS;
DOGS;
ENDEMIC DISEASES;
HUMANS;
IMMUNOGLOBULINS;
INJECTIONS, INTRADERMAL;
RABIES;
RABIES VACCINES;
RABIES VIRUS;
CHLOROQUINE;
DRUG INTERACTIONS;
INJECTIONS, INTRAMUSCULAR;
MALARIA;
DEVELOPING COUNTRIES;
SALIVA;
TIME FACTORS;
|
EID: 16844365374
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200504143521522 Document Type: Letter |
Times cited : (2)
|
References (0)
|